Literature DB >> 12399266

Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects.

Ursula Schwab1, Anneli Törrönen, Leena Toppinen, Georg Alfthan, Markku Saarinen, Antti Aro, Matti Uusitupa.   

Abstract

BACKGROUND: Betaine (trimethylglycine) is found in several tissues in humans. It is involved in homocysteine metabolism as an alternative methyl donor and is used in the treatment of homocystinuria in humans. In pigs, betaine decreases the amount of adipose tissue.
OBJECTIVE: The aim of the study was to examine the effect of betaine supplementation on body weight, body composition, plasma homocysteine concentrations, blood pressure, and serum total and lipoprotein lipids.
DESIGN: Forty-two obese, white subjects (14 men, 28 women) treated with a hypoenergetic diet were randomly assigned to a betaine-supplemented group (6 g/d) or a control group given placebo for 12 wk. The intervention period was preceded by a 4-wk run-in period with a euenergetic diet.
RESULTS: Body weight, resting energy expenditure, and fat mass decreased significantly in both groups with no significant difference between the groups. Plasma homocysteine concentrations decreased in the betaine group ( +/- SD: 8.76 +/- 1.63 micro mol/L at 4 wk, 7.93 +/- 1.52 micro mol/L at 16 wk; P = 0.030 for the interaction of time and treatment). Diastolic blood pressure decreased without a significant difference between the groups. Serum total and LDL-cholesterol concentrations were higher in the betaine group than in the control group (P < 0.05).
CONCLUSION: A hypoenergetic diet with betaine supplementation (6 g daily for 12 wk) decreased the plasma homocysteine concentration but did not affect body composition more than a hypoenergetic diet without betaine supplementation did.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399266     DOI: 10.1093/ajcn/76.5.961

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  42 in total

1.  Betaine supplementation decreases plasma homocysteine in healthy adult participants: a meta-analysis.

Authors:  Marc P McRae
Journal:  J Chiropr Med       Date:  2013-03

2.  Higher serum concentrations of betaine rather than choline is associated with better profiles of DXA-derived body fat and fat distribution in Chinese adults.

Authors:  Y-M Chen; Y Liu; Y-H Liu; X Wang; K Guan; H-L Zhu
Journal:  Int J Obes (Lond)       Date:  2014-08-25       Impact factor: 5.095

3.  In silico and in vivo models for Qatari-specific classical homocystinuria as basis for development of novel therapies.

Authors:  Hesham M Ismail; Navaneethakrishnan Krishnamoorthy; Nader Al-Dewik; Hatem Zayed; Nura A Mohamed; Valeria Di Giacomo; Sapna Gupta; Johannes Häberle; Beat Thöny; Henk J Blom; Waren D Kruger; Tawfeg Ben-Omran; Gheyath K Nasrallah
Journal:  Hum Mutat       Date:  2018-11-23       Impact factor: 4.878

4.  Enhanced hepatic cholesterol accumulation induced by maternal betaine exposure is associated with hypermethylation of CYP7A1 gene promoter.

Authors:  Nannan Zhao; Shu Yang; Yue Feng; Bo Sun; Ruqian Zhao
Journal:  Endocrine       Date:  2019-03-28       Impact factor: 3.633

Review 5.  Choline and betaine in health and disease.

Authors:  Per Magne Ueland
Journal:  J Inherit Metab Dis       Date:  2010-05-06       Impact factor: 4.982

6.  Dietary Betaine Supplementation Increases Fgf21 Levels to Improve Glucose Homeostasis and Reduce Hepatic Lipid Accumulation in Mice.

Authors:  Asma Ejaz; Laura Martinez-Guino; Allison B Goldfine; Francesc Ribas-Aulinas; Valeria De Nigris; Sílvia Ribó; Alba Gonzalez-Franquesa; Pablo M Garcia-Roves; Elizabeth Li; Jonathan M Dreyfuss; Walt Gall; Jason K Kim; Teodoro Bottiglieri; Francesc Villarroya; Robert E Gerszten; Mary-Elizabeth Patti; Carles Lerin
Journal:  Diabetes       Date:  2016-02-08       Impact factor: 9.461

7.  Folate intake at RDA levels is inadequate for Mexican American men with the methylenetetrahydrofolate reductase 677TT genotype.

Authors:  Claudia Solis; Kristin Veenema; Alexandre A Ivanov; Sally Tran; Rui Li; Wei Wang; David J Moriarty; Charles V Maletz; Marie A Caudill
Journal:  J Nutr       Date:  2008-01       Impact factor: 4.798

8.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

Review 9.  Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis.

Authors:  Steven H Zeisel
Journal:  Clin Chem Lab Med       Date:  2013-03-01       Impact factor: 3.694

10.  The association between betaine and choline intakes and the plasma concentrations of homocysteine in women.

Authors:  Stephanie E Chiuve; Edward L Giovannucci; Susan E Hankinson; Steven H Zeisel; Lauren W Dougherty; Walter C Willett; Eric B Rimm
Journal:  Am J Clin Nutr       Date:  2007-10       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.